Roles of chemokines and receptor polarization in NK-target cell interactions. 1998

M Nieto, and F Navarro, and J J Perez-Villar, and M A del Pozo, and R González-Amaro, and M Mellado, and J M Frade, and C Martínez-A, and M López-Botet, and F Sánchez-Madrid
Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.

We report that the ability of NK cells to produce chemokines is increased in NK-target cell conjugates. The chemokines produced play a critical role in the polarization and recruitment of NK cells as well as in the NK effector-target cell conjugate formation. Chemokines induce the formation of two specialized regions in the NK cell: the advancing front or leading edge, where chemokine receptors CCR2 and CCR5 cluster, which might guide the cells toward the chemotactic source, and the uropod, where adhesion molecules ICAM-1 and -3 are redistributed. NK cell polarity was intrinsically involved in conjugate formation. The redistribution of both adhesion receptors and CCR was preserved during the formation of NK-target cell conjugates. Time-lapse videomicroscopy studies of the formation of effector-target conjugates showed that morphologic poles are also functionally distinct; while the binding to target cells was preferentially mediated through the leading edge, the uropod was found at the rear of migrating NK cells and recruited additional NK cells to the vicinity of K562 target cells. Inhibition of cell polarization and adhesion receptor redistribution blocked the formation of NK-K562 cell conjugates and the cytotoxic activity of NK cells. We discuss the implication of NK-cell polarization in the development of cytotoxic responses.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D011940 Receptor Aggregation Chemically stimulated aggregation of cell surface receptors, which potentiates the action of the effector cell. Aggregation, Receptor,Capping, Receptor,Receptor Capping
D002450 Cell Communication Any of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP. Cell Interaction,Cell-to-Cell Interaction,Cell Communications,Cell Interactions,Cell to Cell Interaction,Cell-to-Cell Interactions,Communication, Cell,Communications, Cell,Interaction, Cell,Interaction, Cell-to-Cell,Interactions, Cell,Interactions, Cell-to-Cell
D002451 Cell Compartmentation A partitioning within cells due to the selectively permeable membranes which enclose each of the separate parts, e.g., mitochondria, lysosomes, etc. Cell Compartmentations,Compartmentation, Cell,Compartmentations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002634 Chemotaxis, Leukocyte The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction. Leukotaxis,Leukocyte Chemotaxis
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D004915 Leukemia, Erythroblastic, Acute A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood. Di Guglielmo's Disease,Erythremic Myelosis,Erythroblastic Leukemia, Acute,Erythroleukemia,Leukemia, Myeloid, Acute, M6,Myeloid Leukemia, Acute, M6,Di Guglielmo Disease,Acute Erythroblastic Leukemia,Acute Erythroblastic Leukemias,Di Guglielmos Disease,Disease, Di Guglielmo,Disease, Di Guglielmo's,Erythremic Myeloses,Erythroblastic Leukemias, Acute,Erythroleukemias,Leukemia, Acute Erythroblastic,Leukemias, Acute Erythroblastic,Myeloses, Erythremic,Myelosis, Erythremic

Related Publications

M Nieto, and F Navarro, and J J Perez-Villar, and M A del Pozo, and R González-Amaro, and M Mellado, and J M Frade, and C Martínez-A, and M López-Botet, and F Sánchez-Madrid
June 1987, Shi yan sheng wu xue bao,
M Nieto, and F Navarro, and J J Perez-Villar, and M A del Pozo, and R González-Amaro, and M Mellado, and J M Frade, and C Martínez-A, and M López-Botet, and F Sánchez-Madrid
December 1983, Journal of immunology (Baltimore, Md. : 1950),
M Nieto, and F Navarro, and J J Perez-Villar, and M A del Pozo, and R González-Amaro, and M Mellado, and J M Frade, and C Martínez-A, and M López-Botet, and F Sánchez-Madrid
January 1982, Cancer metastasis reviews,
M Nieto, and F Navarro, and J J Perez-Villar, and M A del Pozo, and R González-Amaro, and M Mellado, and J M Frade, and C Martínez-A, and M López-Botet, and F Sánchez-Madrid
January 1990, Cytopathology : official journal of the British Society for Clinical Cytology,
M Nieto, and F Navarro, and J J Perez-Villar, and M A del Pozo, and R González-Amaro, and M Mellado, and J M Frade, and C Martínez-A, and M López-Botet, and F Sánchez-Madrid
July 1983, Immunobiology,
M Nieto, and F Navarro, and J J Perez-Villar, and M A del Pozo, and R González-Amaro, and M Mellado, and J M Frade, and C Martínez-A, and M López-Botet, and F Sánchez-Madrid
October 1995, Journal of immunology (Baltimore, Md. : 1950),
M Nieto, and F Navarro, and J J Perez-Villar, and M A del Pozo, and R González-Amaro, and M Mellado, and J M Frade, and C Martínez-A, and M López-Botet, and F Sánchez-Madrid
October 1984, Journal of immunology (Baltimore, Md. : 1950),
M Nieto, and F Navarro, and J J Perez-Villar, and M A del Pozo, and R González-Amaro, and M Mellado, and J M Frade, and C Martínez-A, and M López-Botet, and F Sánchez-Madrid
January 2004, Trends in immunology,
M Nieto, and F Navarro, and J J Perez-Villar, and M A del Pozo, and R González-Amaro, and M Mellado, and J M Frade, and C Martínez-A, and M López-Botet, and F Sánchez-Madrid
January 2018, Frontiers in immunology,
M Nieto, and F Navarro, and J J Perez-Villar, and M A del Pozo, and R González-Amaro, and M Mellado, and J M Frade, and C Martínez-A, and M López-Botet, and F Sánchez-Madrid
July 2019, Scientific reports,
Copied contents to your clipboard!